Paris, France – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, is showcasing its latest cardiac care innovations at the ESC Congress 2019 (Paris, France, August 31 – September 4). At the congress, Philips is showcasing Release 5.0 of its EPIQ CVx cardiology platform for the first time in Europe. The platform includes automated applications for 2D assessment of the heart, as well as robust 3D right ventricle volume and ejection fraction measurements, making accurate exams faster and easier to conduct [1]. Philips also announced that it is collaborating with digital health company LindaCare to combine the company’s innovative OnePulse™ cloud-based solution for the remote monitoring of patients with cardiac implantable electronic devices (CIEDs) with the Philips IntelliSpace Cardiovascular informatics platform.
“Monitoring and follow-up of cardiac arrhythmia patients with CIEDs can be often complex, with data trapped in different silos that need to be reviewed individually,” said Calum Cunningham, Business Leader for Enterprise Diagnostic Informatics at Philips. “LindaCare’s innovative OnePulse solution consolidates this data, and by incorporating OnePulse into our IntelliSpace Cardiovascular platform, caregivers can see this additional information as part of the broader cardiovascular history of each patient, allowing them to make the most appropriate treatment decisions for each patient."
Philips IntelliSpace Cardiovascular is a web-based image and workflow management platform which streamlines the workflow of cardiology departments and across hospitals by consolidating multi-modality images and data and enabling access to an open ecosystem of cardiovascular software applications. The seamless combination of IntelliSpace Cardiovascular with LindaCare’s OnePulse solution allows clinicians to more easily access data from their patients’ CIEDs remotely. This results in a more seamless overall workflow, including alert management and triaging, supporting more proactive care. Philips is also introducing a new module on IntelliSpace Cardiovascular which complements the remote monitoring workflow by automating, standardizing and streamlining reporting for patients with CIEDs during hospital visits. Both the OnePulse interface and the new module will be available on the platform later this year. Since 2018, Philips has owned a minority interest in LindaCare through Philips Health Technology Ventures, which manages a business-agnostic digital health fund investing capital in future partners to help drive Philips’ digital transformation and jointly achieve the Quadruple Aim in healthcare.
